Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Randomized Trial of Ghrelin in Anterior Circulation Ischemic Stroke Treated With Endovascular Thrombectomy. A Randomized Phase 2 Trial

NCT05726240 is registered in ClinicalTrials.gov with Rijnstate Hospital as lead sponsor.

NCT NCT05726240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05726240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Randomized Trial of Ghrelin in Anterior Circulation Ischemic Stroke Treated With Endovascular Thrombectomy. A Randomized Phase 2 Trial
Lead sponsor
Rijnstate Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2023
Completion date
December 31, 2024
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, ischemic